CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
CROSSJECT's ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
ALK, a global specialty pharmaceutical company, presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, ...
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する